pharmaceutical investing Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine
Biotie Therapies Corp. Announces That the Delisting of Its American Depositary Shares from NASDAQ Global Select Market Has Become Effective
LaFleur Minerals Continues to Expand Swanson Gold Deposit Mineralization Near Surface and Along Strike with 2.52 g/t Au over 14.35 Metres
Transition Metals Advances Saturday Night with Deep-Penetrating Geophysics, Reports 2026 Summer Exploration Results